loading

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -24.40
Operating Expenses
2.12%
16.45
16.81 - 11.34 7.2948
Operating Income/Loss
2.12%
-16.45
-16.81 - -11.34 -31.69
Income/Loss From Continuing Operations Before Tax
1.67%
-15.54
-15.80 -10.85 -10.41 -6.267
Income/Loss From Continuing Operations After Tax
1.67%
-15.54
-15.80 -10.85 -10.41 -6.267
Net Income/Loss
1.67%
-15.54
-15.80 -10.85 -10.41 -6.267
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - 22.67
Basic Average Shares
98.56%
0.5728
39.74 - 36.58 -
Diluted Average Shares
98.56%
0.5728
39.74 - 36.58 -
Basic Earnings Per Share
5.00%
-0.38
-0.40 - -0.28 -
Diluted Earnings Per Share
5.00%
-0.38
-0.40 - -0.28 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$26.98
price down icon 0.99%
$47.05
price up icon 3.03%
$52.97
price up icon 3.11%
$88.06
price down icon 0.83%
ONC ONC
$272.99
price down icon 1.11%
$146.63
price up icon 6.51%
Kapitalisierung:     |  Volumen (24h):